CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells.

Levi Rupp, Kathrin Schumann, Kole T Roybal, Alexander Marson, Wendell A Lim. CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells. The Journal of Immunology. 2016 May 1; 196(1_Supplement):214.24-214.24.

2016
https://researcherprofiles.org/profile/366877364

Levi Rupp, Kathrin Schumann, Kole T Roybal, Alexander Marson, Wendell A Lim